Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 13/20 | 0.57 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | USP1 | O94782 | 3/20 | 0.37 |
| ▸ | WDR48 | Q8TAF3 | 3/20 | 0.37 |
| ▸ | USP7 | Q93009 | 1/20 | 0.37 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7404546 | 0.80 | NOTUM (0.58) | NOTUMKEAP1CYP19A1 | |
| SCHEMBL20437909 | 0.79 | NOTUM (0.58) | NOTUMKEAP1CYP19A1USP1WDR48 | |
| SCHEMBL24925228 | 0.78 | NOTUM (0.57) | NOTUMKEAP1CYP19A1USP1WDR48 | |
| SCHEMBL20444416 | 0.78 | NOTUM (0.57) | NOTUMKEAP1CYP19A1USP1WDR48 | |
| SCHEMBL2359098 | 0.77 | NOTUM (0.54) | NOTUMKEAP1CYP19A1 | |
| SCHEMBL22325390 | 0.76 | NOTUM (0.53) | NOTUMKEAP1CYP19A1 | |
| SCHEMBL13122736 | 0.75 | NOTUM (0.63) | NOTUMKEAP1CYP19A1 | |
| SCHEMBL27818248 | 0.73 | NOTUM (0.50) | NOTUMKEAP1CYP19A1 | |
| SCHEMBL12794021 | 0.73 | NOTUM (1.00) | NOTUMKEAP1CYP19A1USP1KDM5B | |
| SCHEMBL15362397 | 0.71 | NOTUM (0.65) | NOTUMKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4288429-A1 | LACTAMS AS CBL-B INHIBITORS | Genentech, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| EP-4288428-A1 | AMIDES AS CBL-B INHIBITORS | Genentech, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |